Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
33,940,151
-
Total 13F shares
-
14,295,927
-
Share change
-
+470,238
-
Total reported value
-
$336,848,808
-
Price per share
-
$23.75
-
Number of holders
-
47
-
Value change
-
+$5,601,560
-
Number of buys
-
23
-
Number of sells
-
30
Institutional Holders of TransMedics Group, Inc. - Common Stock (TMDX) as of Q3 2019
As of 30 Sep 2019,
TransMedics Group, Inc. - Common Stock (TMDX) was held by
47 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,295,927 shares.
The largest 10 holders included
ABRAMS CAPITAL MANAGEMENT, L.P., FMR LLC, Flagship Pioneering Inc., CREDIT SUISSE AG/, Zimmer Partners, LP, RTW INVESTMENTS, LP, Sandhill Capital Partners LLC, MASSACHUSETTS FINANCIAL SERVICES CO /MA/, VANGUARD GROUP INC, and BlackRock Inc..
This page lists
47
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.